| Analysis | Metabolite Name | Measured Value | Units | Diagnosis | Dysplasia |
|---|---|---|---|---|---|
| TripleTOF 5600+/C18 NEGATIVE ION MODE | N-(dodecanoyl)-sphing-4-enine; [M-H]-@5.56 | 8129 | Peak area | SCA | N/A |
| TripleTOF 5600+/C18 NEGATIVE ION MODE | N-(dodecanoyl)-sphing-4-enine; [M-H]-@5.56 | 8160 | Peak area | MCN | LGD |
| TripleTOF 5600+/C18 NEGATIVE ION MODE | N-(dodecanoyl)-sphing-4-enine; [M-H]-@5.56 | 8447 | Peak area | MCN | LGD |
| TripleTOF 5600+/C18 NEGATIVE ION MODE | N-(dodecanoyl)-sphing-4-enine; [M-H]-@5.56 | 9817 | Peak area | SCA | N/A |
| TripleTOF 5600+/C18 NEGATIVE ION MODE | N-(dodecanoyl)-sphing-4-enine; [M-H]-@5.56 | 11504 | Peak area | IPMN | LGD |
| TripleTOF 5600+/C18 NEGATIVE ION MODE | N-(dodecanoyl)-sphing-4-enine; [M-H]-@5.56 | 11714 | Peak area | IPMN | LGD |
| TripleTOF 5600+/C18 NEGATIVE ION MODE | N-(dodecanoyl)-sphing-4-enine; [M-H]-@5.56 | 12215 | Peak area | IPMN | LGD |
| TripleTOF 5600+/C18 NEGATIVE ION MODE | N-(dodecanoyl)-sphing-4-enine; [M-H]-@5.56 | 13803 | Peak area | MCN | LGD |
| TripleTOF 5600+/C18 NEGATIVE ION MODE | N-(dodecanoyl)-sphing-4-enine; [M-H]-@5.56 | 13952 | Peak area | IPMN | LGD |
| TripleTOF 5600+/C18 NEGATIVE ION MODE | N-(dodecanoyl)-sphing-4-enine; [M-H]-@5.56 | 14493 | Peak area | SCA | N/A |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|